drugset / Trial / NCT03187093

Cognitive Dysfunction in MDD Patients

NCT03187093

Phase 4 Unknown 150 enrolled Oleg Levada
RandomizedParallel-groupOpen-labelTreatment

Summary

Major Depressive Disorder (MDD) is one of the most prevalent mental diagnosis within the worldwide population. Although there is evidence about relationship between MDD and cognitive dysfunction, still the correlations between biomarkers and the severity of the disorder or the level of cognitive dysfunction need further research. Therefore, the aim of the study is to determine such relationships in Ukrainian population.

Timeline

Start
2016-10
Primary completion
2019-04
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 10 mg
Comparator Escitalopram Small molecule 20 mg
Comparator Vortioxetine Unknown 10 mg
Comparator Vortioxetine Unknown 20 mg